Nanjing Sinolife United Company Limited (3332.HK)
HKD 0.58
(1.75%)
HKD 0.58
(1.75%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 52.6 Million CNY | 469.24% |
| 2022 | -14.24 Million CNY | 55.07% |
| 2021 | -31.7 Million CNY | 36.08% |
| 2020 | -49.6 Million CNY | 74.52% |
| 2019 | -194.65 Million CNY | -72.51% |
| 2018 | -112.83 Million CNY | -2780.85% |
| 2017 | 4.2 Million CNY | -95.17% |
| 2016 | 87.23 Million CNY | -35.97% |
| 2015 | 136.23 Million CNY | 26.29% |
| 2014 | 107.87 Million CNY | 52.39% |
| 2013 | 70.78 Million CNY | 23.67% |
| 2012 | 57.23 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 16.7 Million CNY | 34.82% |
| 2024 Q2 | 16.7 Million CNY | 0.0% |
| 2023 Q4 | 12.39 Million CNY | 0.0% |
| 2023 FY | 52.6 Million CNY | 469.24% |
| 2023 Q1 | 13.91 Million CNY | 407.02% |
| 2023 Q2 | 13.91 Million CNY | 0.0% |
| 2023 Q3 | 12.39 Million CNY | -10.93% |
| 2022 FY | -14.24 Million CNY | 55.07% |
| 2022 Q3 | -4.53 Million CNY | -74.81% |
| 2022 Q2 | -2.59 Million CNY | 0.0% |
| 2022 Q1 | -2.59 Million CNY | 79.13% |
| 2022 Q4 | -4.53 Million CNY | 0.0% |
| 2021 Q4 | -12.42 Million CNY | 0.0% |
| 2021 FY | -31.7 Million CNY | 36.08% |
| 2021 Q3 | -12.42 Million CNY | -261.73% |
| 2021 Q2 | -3.43 Million CNY | 0.0% |
| 2021 Q1 | -3.43 Million CNY | 84.19% |
| 2020 Q3 | -21.71 Million CNY | -603.32% |
| 2020 Q4 | -21.71 Million CNY | 0.0% |
| 2020 Q2 | -3.08 Million CNY | 0.0% |
| 2020 Q1 | -3.08 Million CNY | 95.95% |
| 2020 FY | -49.6 Million CNY | 74.52% |
| 2019 Q4 | -76.19 Million CNY | 0.0% |
| 2019 FY | -194.65 Million CNY | -72.51% |
| 2019 Q1 | -21.13 Million CNY | 63.84% |
| 2019 Q2 | -21.13 Million CNY | 0.0% |
| 2019 Q3 | -76.19 Million CNY | -260.51% |
| 2018 Q4 | -58.45 Million CNY | 0.0% |
| 2018 Q3 | -58.45 Million CNY | -2969.01% |
| 2018 FY | -112.83 Million CNY | -2780.85% |
| 2018 Q2 | 2.03 Million CNY | 0.0% |
| 2018 Q1 | 2.03 Million CNY | 114.06% |
| 2017 Q2 | 16.59 Million CNY | 0.0% |
| 2017 FY | 4.2 Million CNY | -95.17% |
| 2017 Q1 | 16.59 Million CNY | -32.89% |
| 2017 Q4 | -14.49 Million CNY | 0.0% |
| 2017 Q3 | -14.49 Million CNY | -187.32% |
| 2016 FY | 87.23 Million CNY | -35.97% |
| 2016 Q2 | 18.88 Million CNY | 0.0% |
| 2016 Q1 | 18.88 Million CNY | -57.32% |
| 2016 Q4 | 24.73 Million CNY | 0.0% |
| 2016 Q3 | 24.73 Million CNY | 30.94% |
| 2015 Q4 | 44.25 Million CNY | 0.0% |
| 2015 Q2 | 23.86 Million CNY | 0.0% |
| 2015 FY | 136.23 Million CNY | 26.29% |
| 2015 Q1 | 23.86 Million CNY | -36.42% |
| 2015 Q3 | 44.25 Million CNY | 85.44% |
| 2014 Q1 | 16.4 Million CNY | -20.16% |
| 2014 Q4 | 37.53 Million CNY | 0.0% |
| 2014 Q2 | 16.4 Million CNY | 0.0% |
| 2014 FY | 107.87 Million CNY | 52.39% |
| 2014 Q3 | 37.53 Million CNY | 128.84% |
| 2013 Q3 | 20.54 Million CNY | 38.34% |
| 2013 Q4 | 20.54 Million CNY | 0.0% |
| 2013 FY | 70.78 Million CNY | 23.67% |
| 2013 Q1 | 14.85 Million CNY | -4.41% |
| 2013 Q2 | 14.85 Million CNY | 0.0% |
| 2012 Q3 | 15.53 Million CNY | 8.56% |
| 2012 FY | 57.23 Million CNY | 0.0% |
| 2012 Q2 | 14.3 Million CNY | 0.0% |
| 2012 Q1 | 14.3 Million CNY | 0.0% |
| 2012 Q4 | 15.53 Million CNY | 0.0% |
| 2011 Q4 | 14.3 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | -15.11 Million HKD | 448.104% |
| Innovative Pharmaceutical Biotech Limited | 103.4 Million HKD | 49.129% |
| China Overseas Nuoxin International Holdings Limited | -15.5 Million HKD | 439.215% |
| Prosperous Future Holdings Limited | -38.74 Million HKD | 235.754% |
| Huasheng International Holding Limited | -31.44 Million HKD | 267.304% |
| Fourace Industries Group Holdings Limited | 38.71 Million HKD | -35.866% |
| Evergreen Products Group Limited | 51.01 Million HKD | -3.119% |
| EC Healthcare | -18.94 Million HKD | 377.627% |
| Ming Fai International Holdings Limited | 104.18 Million HKD | 49.509% |
| Blue Moon Group Holdings Limited | 325.3 Million HKD | 83.83% |
| SuperRobotics Holdings Limited | -27.75 Million HKD | 289.516% |
| Takbo Group Holdings Limited | 14.65 Million HKD | -258.862% |
| Hyfusin Group Holdings Limited | 102.28 Million HKD | 48.574% |